Delivery Order SPE2DB22D2211-SPE2DB25FSFLB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,848.26 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on September 4, 2025, with a completion date of September 5, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.27 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pen 3ml on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at approximately $22K, with an ultimate completion date of September 3, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $19,602.93 delivery order to AmerisourceBergen Drug Corp for Ozempic (0.25-0.5 mg/dose pen, 3ml) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency has awarded a $3,574.08 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is structured as a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,435.30 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,134.45 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,198.61 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,519.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of August 1, 2025. This non-set-aside competitive award was issued on July 31, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $1,253.32. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. As a child contract, this...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFLBDelivery Order
The Defense Logistics Agency awarded a $49,303 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, supplying the diabetes medication to support federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, leveraging its comprehensive pharmaceutical distribution capabilities to support military and veteran healthcare systems. The company's $999,999,999 IDC vehicle enables it to supply an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. This delivery order for Ozempic exemplifies the vendor's role in providing essential medications to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through a flexible contract structure designed to meet diverse medical supply requirements across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.3k | 9/19/25 |